Clinical Trials Browser

Vaccines, DNA × Head & Neck × Clear all

NCT05799144 2025-10-22

pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer

Phase 2 Recruiting

Oropharyngeal Neoplasms

NCT01493154 2018-11-23

Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer Patients

Phase 1 Terminated

Head and Neck Neoplasms, Sexually Transmitted Diseases, Viral